INTERWEST PARTNERS X LP - 02 Dec 2021 Form 4 Insider Report for Doximity, Inc. (DOCS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Dec 2021, 19:00:13 UTC
Prior SEC filing
15 Nov 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Karen A. Wilson, Attorney-in Fact for InterWest Partners X, LP

Key filing fact

INTERWEST PARTNERS X LP filed Form 4 for Doximity, Inc. (DOCS) on 06 Dec 2021.

Key facts

  • This page summarizes INTERWEST PARTNERS X LP's Form 4 filing for Doximity, Inc. (DOCS).
  • 7 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 06 Dec 2021, 19:00.

Change

  • Previous filing in this sequence was filed on 15 Nov 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DOCS transaction

Class A Common Stock

Conversion of derivative security

Transaction value
Shares
+4,300,000
Change %
Price
Shares after
4,300,000
Date
02 Dec 2021
Ownership
Direct
Footnotes
F1, F4
DOCS transaction

Class A Common Stock

Other

Transaction value
$0
Shares
-4,300,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
02 Dec 2021
Ownership
Direct
Footnotes
F2
DOCS transaction

Class A Common Stock

Other

Transaction value
$0
Shares
+1,101,094
Change %
Price
$0.000000
Shares after
1,101,094
Date
02 Dec 2021
Ownership
By: InterWest Management Partners X, LLC
Footnotes
F2, F4
DOCS transaction

Class A Common Stock

Other

Transaction value
$0
Shares
-1,101,094
Change %
-100%
Price
$0.000000*
Shares after
0
Date
02 Dec 2021
Ownership
By: InterWest Management Partners X, LLC
Footnotes
F3, F4
DOCS transaction

Class A Common Stock

Other

Transaction value
$0
Shares
+41,070
Change %
+101%
Price
$0.000000
Shares after
81,696
Date
02 Dec 2021
Ownership
By: Khaled A. Nasr
Footnotes
F3, F4
DOCS transaction

Class A Common Stock

Other

Transaction value
$0
Shares
+27,527
Change %
+101%
Price
$0.000000
Shares after
54,756
Date
02 Dec 2021
Ownership
By: Keval Desai
Footnotes
F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DOCS transaction Derivative

Class B Common Stock

Conversion of derivative security

Transaction value
$0
Shares
-4,300,000
Change %
-33%
Price
$0.000000
Shares after
8,556,998
Date
02 Dec 2021
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
4,300,000
Exercise price
Footnotes
F1, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

INTERWEST PARTNERS X LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 5 footnotes

Footnote F1

Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder.

Footnote F2

Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 1,101,094 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner.

Footnote F3

Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 41,070 shares distributed to Khaled A. Nasr ("Nasr"), 27,527 shares distributed to Keval Desai ("Desai") and 249,778 shares distributed to Gilbert H. Kliman ("Kliman"), as reported on Kliman's separate Form 4 in his own name.

Footnote F4

These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein.

Footnote F5

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class.

SEC remarks

Gilbert H. Kliman, a Managing Director of IMP10, is also a Director of the Issuer and has filed a separate Form 4 in his own name.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .